Analysis of Time-To-Onset and Onset-Pattern of Interstitial Lung Disease After the Administration of Monoclonal Antibody Agents

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.18-00094
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Analysis of Time-To-Onset of Interstitial Lung Disease After the Administration of Small Molecule Molecularly-Targeted Drugs

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2018English

Interstitial Lung Disease Caused by STING-associated Vasculopathy With Onset in Infancy

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2016English

The Dose Effect of Ephedrine on the Onset Time and Intubating Conditions After Cisatracurium Administration

Korean Journal of Anesthesiology
AnesthesiologyPain Medicine
2014English

Cyclophosphamide-Induced Late-Onset Lung Disease.

Internal Medicine
Internal MedicineMedicine
2003English

THU0528 Sting-Associated Vasculopathy With Onset in Infancy (SAVI): A Differential Diagnosis of Inflammatory Interstitial Lung Disease

2017English

Molecular Analysis of Late Onset Huntington's Disease.

Journal of Medical Genetics
Genetics
1993English

Anti-Interleukin-1 Agents in Adult Onset Still's Disease

International Journal of Inflammation
AllergyImmunology
2012English

Comparison of Etomidate and Propofol on Intubating Conditions and the Onset Time Associated With Cisatracurium Administration

Korean Journal of Anesthesiology
AnesthesiologyPain Medicine
2015English

Seasonal Onset of Hodgkin's Disease

BMJ
1965English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy